Stock for Your Case: Eli Lilly and Company (NYSE:LLY)


LLY's value Change from Open was at 0.26% with a Gap of -0.28%.

Many Analysts provided their foresight on Revenue Estimates of Eli Lilly and Company where they believe that the company has the potential to earn average revenue of $5.2 Billion for the current quarter. 1 analysts recommended Overweight these shares while 0 recommended Underweight, according to FactSet data. Eli Lilly and now has a consensus rating of Buy and a consensus price target of $89.36. The stock has relative volume of 0.35. North Star Asset Management Inc. acquired a new stake in shares of Eli Lilly and Company during the second quarter valued at about $225,000. The company had Year Ago Sales of $32.6 Billion. Following the transaction, the insider now directly owns 94,319 shares of the company's stock, valued at $7,674,737.03. Morgan Stanley set a $73.00 price objective on shares of Eli Lilly and Company and gave the company a "hold" rating in a research report on Thursday, November 24th. Currently, the company has SMA200 (200-day simple moving average) of 2.14 Percent. The company's P/E is 18.98 and Forward P/E ratio is 13.28.

Eli Lilly and Company (NYSE:LLY) last posted its quarterly earnings results on Tuesday, January 31st.

Eli Lilly and Company (NYSE:LLY) has a market capitalization of 82.68 Billion.

Debate Over Bill Exposes Rift In Texas' Anti-Abortion Community
And Senate Bill 258 would require abortion doctors to offer women the option of having fetal remains buried or cremated. SB 8 would also extend the federal ban on partial-birth abortions, a procedure ruled unconstitutional by the U.S.

02/10/2016 - Eli Lilly and Company had its "buy" rating reiterated by analysts at Deutsche Bank.

EPS growth in next year is estimated to reach 7.00% while EPS growth estimate for this year is set at 14.10%. The stock touched its high share price of $83.79 on Aug 1, 2016 and the stock also touched its Lowest price in the last 52-weeks of trading on Nov 23, 2016 as $64.18. 11 analysts projected on average Earnings. Shareholders of record on Wednesday, February 15th will be issued a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a yield of 2.67%. This is a boost from Eli Lilly and's previous quarterly dividend of $0.51. The ex-dividend date is Monday, February 13th. Ashburton Jersey Ltd's holdings in Eli Lilly and Company were worth $2,137,000 as of its most recent SEC filing.

"Russell Investments Group Ltd. Purchases Shares of 717,601 Eli Lilly and Company (LLY)" was first posted by Community Financial News and is owned by of Community Financial News. If you are viewing this story on another publication, it was illegally copied and reposted in violation of USA and worldwide copyright legislation. The correct version of this story can be viewed at Recently, investment analysts covering the stock have updated the mean rating to 2. Zacks Investment Research downgraded Eli Lilly and Company from a "buy" rating to a "hold" rating in a report on Wednesday. According to Thomson Reuters, sell-side analysts are forecasting a harmony target price of $84.54 on company shares. A stock ATR is the difference between the high and low price on any given day.

11/07/2016 - Eli Lilly and Company had its "buy" rating reiterated by analysts at Citigroup. MDT right now sits at consensus rating of 2.10 while 11 analysts have advocated the shares as "BUY", 6 calls it an "OUTPERFORM" and 9 suggest "HOLD".

Oroville Dam: Residents advised to remain vigilant as storm advances
The main spillway , a separate channel, also is damaged because part of its concrete lining crumbled last week. Water gushes from the Oroville Dam's main spillway in Oroville, Calif. on February 14, 2017.

US based company, Eli Lilly and Company's (LLY)'s latest closing price distance was 2.14% from the average-price of 200 days while it maintained a distance from the 50 Day Moving Average at 5.44% and 1.36% compared with the 20 Day Moving Average.

Insider Trades for Eli Lilly and Company show that the latest trade was made on 5 Feb 2017 where Zulueta Alfonso G, the Officer completed a transaction type "Sell" in which 15000 shares were traded at a price of $77.66.

While trading at volume below than average, Medtronic plc (NYSE:MDT) previous 52-week high was $88.74 and moved up 4.43% over the same period, trading at a volume of 4.24 million. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. The Average Volume (3 months) is 6.11 Million.

Gold prices gain in Asia as Dudley views on rates shrugegd off
Bears' next near-term downside price breakout objective is pushing prices below solid technical support at $1,200.00. Yellen's comments boosted appetite for assets perceived as higher risk, like equities, as well as the dollar.